This inventor holds 1 USPTO granted patent. Top assignee: Terumo Kabushiki Kaisha. Active years: 1994.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1994
Title: Ryohei Yanoshita: Innovator in Pharmaceutical Compounds
Introduction
Ryohei Yanoshita is an esteemed inventor based in Kanagawa, Japan, known for his contributions to the field of pharmaceuticals. With a focused expertise in sulfonamide compounds, he has successfully translated his innovative ideas into practical applications that hold potential benefits within the medical community.
Latest Patents
Yanoshita's notable patent involves N-(3-pyridylalkyl)sulfonamide compounds. This invention is no ordinary feat; it describes derivative compounds that serve vital functions, such as being a thromboxane A2 production inhibitor, a thromboxane A2 antagonist, a prostaglandin H2 antagonist, an anti-thrombus agent, a thrombus-preventing agent, and an anti-allergy agent. The illustrative chemical formulations labeled as [II] and [III] reflect the systematic innovation behind his work.
Career Highlights
Yanoshita's career is marked by his affiliation with Terumo Kabushiki Kaisha, where he actively contributes to the company's research and development initiatives. His focused research in pharmacological applications underscores his dedication to enhancing therapeutic interventions.
Collaborations
In his pursuit of innovation, Yanoshita has collaborated with fellow researchers, such as Hiroyuki Ohnishi and Masazumi Miyakoshi. This synergy not only enhances the creative process but also allows for the pooling of knowledge and expertise, ultimately benefitting the research outcomes.
Conclusion
Ryohei Yanoshita’s contributions as an inventor and his recent patent showcase the importance of innovative thinking in the pharmaceutical industry. His work exemplifies the potential to create useful compounds that can address various medical challenges, positioning him as a notable figure in his field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
